0002145373-26-000001.txt : 20260714 0002145373-26-000001.hdr.sgml : 20260714 20260714123650 ACCESSION NUMBER: 0002145373-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260714 DATE AS OF CHANGE: 20260714 EFFECTIVENESS DATE: 20260714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sailie Bio, Inc. CENTRAL INDEX KEY: 0002145373 ORGANIZATION NAME: EIN: 393865665 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590677 FILM NUMBER: 261173356 BUSINESS ADDRESS: STREET 1: 38 WAREHAM ST FL 3 CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: 617-302-6644 MAIL ADDRESS: STREET 1: 38 WAREHAM ST FL 3 CITY: BOSTON STATE: MA ZIP: 02118 D 1 primary_doc.xml X0708 D LIVE 0002145373 Sailie Bio, Inc. 38 WAREHAM ST FL 3 BOSTON MA MASSACHUSETTS 02118 617-302-6644 DELAWARE None None Corporation true 2025 Gregory Philip Dracoulis 38 Wareham St Fl 3 Boston MA MASSACHUSETTS 02118 Executive Officer Director Promoter President and Chief Executive Officer Biotechnology No Revenues 06b false 2026-06-28 false true Simple Agreement for Future Equity (SAFE) false 0 250000 100000 150000 false 2 0 0 100000 true Estimate includes ordinary course executive compensation and reimbursement of out of pocket startup expenses. false Sailie Bio, Inc. Gregory Philip Dracoulis Gregory Philip Dracoulis President and Chief Executive Officer 2026-07-14